Premium
RAPT Therapeutics Inc (RAPT)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX... RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -2.5 | 1.2 | 1.32 | 1.1 | 413206 | 1.19964611 | CS |
| 4 | -0.04 | -3.30578512397 | 1.21 | 1.32 | 1.07 | 447415 | 1.17071432 | CS |
| 12 | 0.13 | 12.5 | 1.04 | 2.32 | 0.78925 | 3698178 | 1.64834733 | CS |
| 26 | -1.26 | -51.8518518519 | 2.43 | 3.32 | 0.78925 | 1887713 | 1.66266359 | CS |
| 52 | -8.41 | -87.7870563674 | 9.58 | 10.05 | 0.78925 | 1297804 | 2.94221319 | CS |
| 156 | -17.62 | -93.7732836615 | 18.79 | 32.45 | 0.78925 | 721886 | 9.22477825 | CS |
| 260 | -22.13 | -94.9785407725 | 23.3 | 43.26 | 0.78925 | 558592 | 14.00381287 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
